Nathan Bryan

Nitric Oxide Innovations Drug Company Founder and CEO, Nathan Bryan Ph.D, Engages Alan Morell, Creative Management Partners (CMP), as Senior Advisor for Worldwide Licensing, Media Positioning Representation

Retrieved on: 
Wednesday, June 16, 2021

BEVERLY HILLS, CA, June 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Announced today: Nitric Oxide Innovationsdrug companyCEO, Nathan Bryan Ph.D,engages Alan Morell, Creative Management Partners (CMP) as Senior Advisorfor Worldwide Licensing, Media positioning, representation of Dr. Bryans Literary, Broadcast, Consulting and Speaking Engagements.

Key Points: 
  • BEVERLY HILLS, CA, June 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Announced today: Nitric Oxide Innovationsdrug companyCEO, Nathan Bryan Ph.D,engages Alan Morell, Creative Management Partners (CMP) as Senior Advisorfor Worldwide Licensing, Media positioning, representation of Dr. Bryans Literary, Broadcast, Consulting and Speaking Engagements.
  • Said Nathan S. Bryan Ph.D: "Nitric Oxide Innovations is a clinical stage pharmaceutical company focused on nitric oxide based therapeutics.
  • NOviricid is a nitric oxide releasing lozenge designed to replete and restore nitric oxide in patients that are nitric oxide deficient and therefore at increased risk of illness from COVID.
  • Our NOviricid drug is a nitric oxide donor that releases 40ppm nitric oxide gas over 5 minutes as the lozenge is dissolving.

Global Nitric Oxide Market Research Report 2020: Pathways, Role of NO in Physiology & Diseases, Therapeutic Applications, Drug Evaluation, Markets & Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, November 6, 2020

The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
  • Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.
  • It also functions as a signaling molecule and has an important role in the pathogenesis of several diseases.

New Book Functional Nitric Oxide Nutrition Serves as a Preventive Guide to Treating Chronic Disease

Retrieved on: 
Thursday, March 26, 2020

AUSTIN, Texas, March 26, 2020 /PRNewswire/ --Dr. Nathan Bryan, Ph.D., renowned expert on nitric oxide science, released his book,Functional Nitric Oxide Nutrition: Dietary Strategies to Prevent Chronic Disease,on one of the most important and mysterious molecules known to mankind: nitric oxide (NO).

Key Points: 
  • AUSTIN, Texas, March 26, 2020 /PRNewswire/ --Dr. Nathan Bryan, Ph.D., renowned expert on nitric oxide science, released his book,Functional Nitric Oxide Nutrition: Dietary Strategies to Prevent Chronic Disease,on one of the most important and mysterious molecules known to mankind: nitric oxide (NO).
  • This book is an accessible guide for medical professionals and consumers, offering up the newest scientific and medical information about nitric oxide.
  • "After 20 years of research and traveling the world to lecture and educate on nitric oxide, I realized that too few people knew about nitric oxide, including physicians and health care practitioners.
  • Bryan is an innovator of nitric oxide product technology and has recently developed the first and only nitric oxide based anti-aging skincare serum.

Nitric Oxide Product Receives Overwhelming Response at A4M Anti-Aging Convention

Retrieved on: 
Wednesday, February 19, 2020

As an international leader in molecular medicine and nitric oxide biochemistry, Dr. Bryan has devoted 20 years of research to the therapeutic use of nitric oxide to counter the effects of aging including cardiovascular disease.

Key Points: 
  • As an international leader in molecular medicine and nitric oxide biochemistry, Dr. Bryan has devoted 20 years of research to the therapeutic use of nitric oxide to counter the effects of aging including cardiovascular disease.
  • "Nitric oxide (NO) is one of the most important molecules produced by the human body."
  • Not only is Pneuma Nitric Oxide the first product of its kind, it is the first of what is becoming a revolution in the skin care industry.
  • Link to before and after images of clients using Pneuma Nitric Oxide Serum: https://app.box.com/s/sb7x1bhqt6gdlqfs1zfka4q6pn3voqnu
    Pneuma Nitric Oxide is a company focused on connecting beauty to wellness with Nitric Oxide-based technology and the highest caliber of ingredients.

Dr. Nathan S. Bryan is the First to Speak at the 27th Annual World Congress About Nitric Oxide's Link to Mental Illness

Retrieved on: 
Thursday, December 12, 2019

LAS VEGAS, Dec. 12, 2019 /PRNewswire/ --On Friday Dec. 13, 2019, Dr. Nathan S. Bryan is the first to speak about the correlation between low nitric oxide levels and mental illness at the 27th Annual World Congress.

Key Points: 
  • LAS VEGAS, Dec. 12, 2019 /PRNewswire/ --On Friday Dec. 13, 2019, Dr. Nathan S. Bryan is the first to speak about the correlation between low nitric oxide levels and mental illness at the 27th Annual World Congress.
  • His many seminal discoveries in the field of nitric oxide has led to dozens of issued U.S. and International Patents.
  • He has published hundreds of peer-reviewed studies on nitric oxide and is considered an international expert on nitric oxide biochemistry and physiology.
  • It is becoming increasingly clear that most if not all diseases are characterized or associated with perturbations in nitric oxide production/signaling.

Nitric Oxide Therapeutics, Markets and Companies Report 2019: Latest Voncepts of the Role of NO in Health and Disease as a Basis for Therapeutics and Development of New Drugs - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 6, 2019

The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
  • Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.
  • It also functions as a signaling molecule and has an important role in the pathogenesis of several diseases.